← SynDRA
ALEGLITAZAR
SynDRA canonical compound SYN0018877 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | PPARA | PPARG |
|---|
| Mechanism of action | ppar receptor agonist |
|---|
| Indication | diabetes mellitus |
|---|
| Disease area | endocrinology |
|---|
All known targets
Mechanisms of action (all sources)
- PPARA AGONIST
- Peroxisome proliferator-activated receptor alpha agonist
- PPARG AGONIST
- Peroxisome proliferator-activated receptor gamma agonist
- ppar receptor agonist
Cross-references
Synonyms
- RO-0728804
- R-1439
- R1439
- RO0728804
- RO7
- Aleglitazar (USAN)
- 2-methoxy-3-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]benzothiophen-7-yl]propanoic Acid
- RO 0728804
- R 1439
- aleglitazarum
- RefChem:110657
- DTXCID80119684
- Aleglitazar [USAN]
- RG-1439
- UNII-41T4OAG59U
- Aleglitazar [USAN:INN]
- ALEGLITAZAR [MI]
- ALEGLITAZAR [INN]
- ALEGLITAZAR [WHO-DD]
- SCHEMBL482284
- GTPL7405
- orb1707695
- SCHEMBL30193480
- DAYKLWSKQJBGCS-NRFANRHFSA-N
- BDBM50277897
- AKOS022185537
- CS-1134
- NCGC00378922-01
- HY-14728
- TS-07953
- RO-728804
- NS00072608
- D08845
- T14176
- RO-0728804-000
- Ro-0728804
- أليغليتازار
- آلگلیتازار
Look up ALEGLITAZAR in the interactive SynDRA portal →